Welcome to your Daily Dose of Health Tech Innovation!
Stay ahead with the latest breakthroughs revolutionizing healthcare—from AI diagnostics to remote care solutions.
We bring you expert-curated insights, emerging trends, and must-know updates from the digital health frontier.
Whether you’re a clinician, innovator, or health tech enthusiast, this roundup delivers what matters most.
Let’s dive into the future of health, one innovation at a time.
Healthcare Drives Practical AI, Fueling 300% YoY Growth at SENA Health
As strain across the US healthcare system continues to build, provider organizations are finding it harder to keep pace with patient demand. Lower reimbursement rates, rising operating expenses, and increasing administrative complexity are putting pressure on practices of every size. Patients often face long wait times and limited access to care, while providers struggle with staffing shortages, inefficient processes, and disconnected systems that slow daily operations.
Novo Nordisk’s Oral Wegovy Now Available Nationwide
Novo Nordisk has made the Wegovy pill widely available in the United States, offering adults seeking weight management a new oral GLP-1 treatment option for the first time. This development provides hope for the more than 100 million Americans living with obesity. The pill was approved on December 22, 2025, for use alongside a reduced-calorie diet and increased physical activity in adults with obesity or those who are overweight with weight-related health conditions. It is designed to help patients lose weight and maintain those results over time.
NewcelX Adds Dr. Julien Boisdron to Scientific Advisory Board
NewcelX Ltd., a biotechnology company focused on developing cell-based and small-molecule therapies for neurodegenerative and metabolic diseases, announced the appointment of Dr. Julien Boisdron, MD, to its Scientific Advisory Board. Dr. Boisdron is an experienced diabetes specialist with more than 20 years of global leadership in the field, including senior roles at Swiss-based multinational pharmaceutical companies. He currently serves as Chief Medical Officer, overseeing the strategic development of next-generation diabetes technologies, clinical programs, and real-world evidence initiatives. His expertise spans connected-care innovation, advanced insulin management systems, and integrating therapeutic and digital solutions to improve patient outcomes.
Flat Medical Appoints Eric Steen, Former B. Braun Executive, as Strategic Advisor
Flat Medical, a leader in precision safety technology for clinical procedures, announced the appointment of Eric Steen as Strategic Advisor. Mr. Steen brings over 25 years of medical device experience, including senior executive roles at B. Braun North America where he led strategic initiatives and commercial execution.
HELUS Pharma Advances Mental Health Therapies, Begins Nasdaq Trading
Cybin Inc. doing business as Helus Pharma, a clinical stage pharmaceutical company committed to helping minds heal by developing NSAs, announced that the Company will operate under the business name Helus Pharma and trade on Nasdaq with ticker symbol HELP.
GeneDx Leads Rare Disease Genomics with Unmatched Research and Clinical Impact in 2025
GeneDx, a leader in delivering improved health outcomes through genomic insights, announced a record-setting year for its Medical Affairs and research programs, reinforcing its position as the global leader in rare disease genomics. In 2025, GeneDx published 79 peer-reviewed studies bringing its total to over 1,100 peer-reviewed studies – all powered by GeneDx Infinity – delivering the most prolific and clinically impactful research portfolios in rare disease genomics.
To share your insights, please write to us at sudipto@intentamplify.com
